Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder

Metabolic Brain Disease

Volumn 33, Issue 3, 2018, Pages 843-854

  Al Otaish, Hanoof ^a   Al Ayadhi, Laila ^b,c   Bjørklund, Geir ^d   Chirumbolo, Salvatore ^e   Urbina, Mauricio A ^f   El Ansary, Afaf ^b,c,g  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Autism Research and Treatment Center   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Department of Research   (Norway)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF CONCEPCIÓN   (Chile)

^g NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

autism; childhood autism rating scale; gamma aminobutyric acid; glutamate excitotoxicity; glutamine; neurotransmitter

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; BIOLOGICAL MARKER;

AMINO ACID BLOOD LEVEL; ARTICLE; AUTISM; CHILD; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; HUMAN; MALE; SENSITIVITY AND SPECIFICITY; SOCIAL COGNITION; ADOLESCENT; BLOOD; COGNITION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR;

ADOLESCENT; AUTISM SPECTRUM DISORDER; BIOMARKERS; CHILD; COGNITION; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR;

EID: 85043500038     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-018-0186-6     Document Type: Article

References (64)

1. APA - American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association Publishing, Arlington. 10.1176/appi.books.9780890425596
2. Balakrishnan S, Dobson KL, Jackson C, Bellamy TC (2014) Ectopic release of glutamate contributes to spillover at parallel fibre synapses in the cerebellum. J Physiol 592(7):1493–1503. 10.1113/jphysiol.2013.267039
3. Bjørklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars) 73(2):225–236
4. Bjørklund G, Chartrand M (2016) Nutritional and environmental influences on autism spectrum disorder. J Nutr Disord Ther 6(01):e123. 10.4172/2161-0509.1000e123
5. Bjørklund G, Saad K, Chirumbolo S, Kern JK, Geier DA, Geier MR, Urbina MA (2016) Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiol Exp (Wars) 76(4):257–268
6. Boddaert N, Zilbovicius M, Philipe A, Robel L, Bourgeois M, Barthélemy C, Seidenwurm D, Meresse I, Laurier L, Desguerre I, Bahi-Buisson N, Brunelle F, Munnich A, Samson Y, Mouren MC, Chabane N (2009) MRI findings in 77 children with non-syndromic autistic disorder. PLoS One 4(2):e4415. 10.1371/journal.pone.0004415
7. Bode BP (2001) Recent molecular advances in mammalian glutamine transport. J Nutr 131:2475S–2485S
8. Breidbord J, Croudace TJ (2013) Reliability generalization for childhood autism rating scale. J Autism Dev Disord 43(12):2855–2865. 10.1007/s10803-013-1832-9
9. Chlebowski C, Green JA, Barton ML, Fein D (2010) Using the childhood autism rating scale to diagnose autism spectrum disorders. J Autism Dev Disord 40(7):787–799. 10.1007/s10803-009-0926-x
10. Choudhury PR, Lahiri S, Rajamma U (2012) Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 100:841–849
11. Christensen DL, Baio J, Braun KV, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M (2016) Prevalence and characteristics of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ 65(3):1–23. 10.15585/mmwr.ss6503a1
12. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ (2012) GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev 36:2044–2055
13. El-Ansary A (2016) Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief 7:111–116. 10.1016/j.dib.2016.02.025
14. El-Ansary A, Al-Ayadhi L (2014) GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation 11(1):189. 10.1186/s12974-014-0189-0
15. El-Ansary A, Bjørklund G, Tinkov AA, Skalny AV, Al Dera H (2017) Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children. Metab Brain Dis 32(4):1073–1080. 10.1007/s11011-017-9996-1
16. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5(3):160–179. 10.1002/aur.239
17. Endreffy I, Bjørklund G, Dicső F, Urbina MA, Endreffy E (2016) Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet. Metab Brain Dis 31(2):273–278. 10.1007/s11011-015-9745-2
18. Fatemi SH (2008) The hyperglutamatergic hypothesis of autism. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):911–911, author reply 913. 10.1016/j.pnpbp.2007.11.004
19. Fatemi SH (2015) The molecular basis of autism. Springer, New York. 10.1007/978-1-4939-2190-4
20. Ghanizadeh A (2013) Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers 35(5):281–286. 10.1155/2013/536521
21. Good P (2013) Dose infectious fever relieves autistic behavior by by releasing glutamine from skeletal muscles as provisional fuel? Med Hypotheses 80(1):1–12. 10.1016/j.mehy.2012.08.035
22. Hall MH, Jensen JE, Du F, Smoller JW, O'Connor L, Spencer KM, Öngür D (2015) Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo. NeuroImage 111:186–191. 10.1016/j.neuroimage.2015.02.014
23. Hawkins RA, O'Kane RL, Simpson IA, Viña JR (2006) Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136(1 Suppl):218S–226S
24. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S (2006) Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129(11):3042–3050. 10.1093/brain/awl279
25. Javitt DC (2004) Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 9(11):984–997. 10.1038/sj.mp.4001551
26. Kadam P, Bhalerao S (2010) Sample size calculation. Int J Ayurv Res 1:55–57
27. Kim SK, Nabekura J, Koizumi S (2017) Astrocyte-mediated synapse remodeling in the pathological brain. Glia 65:1719–1727
28. Kwong WH, Chan WY, Lee KK, Fan M, Yew DT (2000) Neurotransmitters, neuropeptides and calcium binding proteins in developing human cerebellum: a review. Histochem J 32(9):521–534. 10.1023/A:1004197210189
29. Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA (2014) Economic burden of childhood autism spectrum disorders. Pediatrics 133(3):e520–e529. 10.1542/peds.2013-0763
30. LeBlanc JJ, Fagiolini M (2011) Autism: a “critical period” disorder? Neural Plast 2011:921680. 10.1155/2011/921680
31. Maltezos S, Horder J, Coghlan S, Skirrow C, O'Gorman R, Lavender TJ, Mendez MA, Mehta M, Daly E, Xenitidis K, Paliokosta E, Spain D, Pitts M, Asherson P, Lythgoe DJ, Barker GJ, Murphy DG (2014) Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. Transl Psychiatry 4(3):e373. 10.1038/tp.2014.11
32. Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM, Brown WD, Hacein-Bey L (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol 22(10):1813–1824
33. Matelski L, van de Water J (2016) Risk factors in autism: thinking outside the brain. J Autoimmun 67:1–7. 10.1016/j.jaut.2015.11.003
34. McKenna M, Gruetter R, Sonnerwald U, Waagepetersen HS, Schousboe A (2011) Energy metabolism of the brain. Basic neurochemistry: principles of molecular, cellular, and medical neurobiology. Elsevier, New York
35. Meguid NA, Anwar M, Bjørklund G, Hashish A, Chirumbolo S, Hemimi M, Sultan E (2017) Dietary adequacy of Egyptian children with autism spectrum disorder compared to healthy developing children. Metab Brain Dis 32(2):607–615. 10.1007/s11011-016-9948-1
36. Mitchell S, Cardy JO, Zwaigenbaum L (2011) Differentiating autism spectrum disorder from other developmental delays in the first two years of life. Dev Disabil Res Rev 17(2):130–140. 10.1002/ddrr.1107
37. Moriyama Y, Hayashi M, Yamada H, Yatsushiro S, Ishio S, Yamamoto A (2000) Synaptic-like microvesicles, synaptic vesicle counterparts in endocrine cells, are involved in a novel regulatory mechanism for the synthesis and secretion of hormones. J Exp Biol 203(Pt 1):117–125
38. Naaijen J, Bralten J, Poelmans G, Glennon JC, Franke B, Buitelaar JK, IMAGE consortium (2017) Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism. Transl Psychiatry 7(1):e999. 10.1038/tp.2016.273
39. Owens DF, Kriegstein AR (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3(9):715–727. 10.1038/nrn919
40. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y (2008) Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 167(3):362–368. 10.1093/aje/kwm305
41. Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314–332. 10.1016/j.pharmthera.2011.09.006
42. Reber M (2012) The autism spectrum: scientific foundations and treatment. Cambridge University Press, Cambridge. 10.1017/CBO9780511978616
43. Reubi JC, Van Der Berg C, Cuénod M (1978) Glutamine as precursor for the GABA and glutamate trasmitter pools. Neurosci Lett 10(1-2):171–174. 10.1016/0304-3940(78)90030-7
44. Rojas DC, Singel D, Steinmetz S, Hepburn S, Brown MS (2014) Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. NeuroImage 86:28–34
45. Rosenberg A, Patterson JS, Angelaki DE (2015) A computational perspective on autism. Proc Natl Acad Sci U S A 112(30):9158–9165. 10.1073/pnas.1510583112
46. Rossignol E (2011) Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast 2011:649325. 10.1155/2011/649325
47. Rudzki PJ, Buś-Kwaśnik K, Kaza M (2017) Incurred sample reanalysis: adjusted procedure for sample size calculation. Bioanalysis 9:1719–1726
48. Rutter M (2005) Autism research: lessons from the past and prospects for the future. J Autism Dev Disord 35:241–257
49. Rutter M, Schopler E (2012) Autism: A reappraisal of concepts and treatment. Springer, Boston
50. Salley B, Miller A, Bell MA (2013) Associations between temperament and social responsiveness in young children. Infant Child Dev 22:270–288
51. Santoro MR, Bray SM, Warren ST (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 7(1):219–245. 10.1146/annurev-pathol-011811-132457
52. Sesarini CV (2015) GABAergic neurotransmission alterations in autism spectrum disorders. Neurotransmitter 2:e1052. 10.14800/nt.1052
53. Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, Matsuzaki H, Iwata K, Matsumoto K, Wakuda T, Kameno Y, Suzuki K, Tsujii M, Nakamura K, Takei N, Mori N (2011) Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 6(10):e25340. 10.1371/journal.pone.0025340
54. Shimmura C, Suzuki K, Iwata Y, Tsuchiya KJ, Ohno K, Matsuzaki H, Iwata K, Kameno Y, Takahashi T, Wakuda T, Nakamura K, Hashimoto K, Mori N (2013) Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism. Mol Autism 4(1):6. 10.1186/2040-2392-4-6
55. Shinohe A, Hashimoto K, Nakamura K, Tsujii M, Iwata Y, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, Sugihara G, Matsuzaki H, Minabe Y, Sugiyama T, Kawai M, Iyo M, Takei N, Mori N (2006) Increased serum levels of glutamate in adult patients with autism. Prog Neuro-Psychopharmacol Biol Psychiatry 30(8):1472–1477. 10.1016/j.pnpbp.2006.06.013
56. Sibilla S, Ballerini L (2009) GABAergic and glycinergic interneuron expression during spinal cord development: dynamic interplay between inhibition and excitation in the control of ventral network outputs. Prog Neurobiol 89(1):46–60. 10.1016/j.pneurobio.2009.06.001
57. Simard M, Nedergaard M (2004) The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129(4):877–896. 10.1016/j.neuroscience.2004.09.053
58. Skuse D, Warrington R, Bishop D, Chowdhury U, Lau J, Mandy W, Place M (2004) The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 43:548–558
59. WMA - World Medical Association (2013) World Medical Association Declaration of Helsinki. JAMA 310(20):2191–2194
60. Wu C, Sun D (2015) GABA receptors in brain development, function, and injury. Metab Brain Dis 30(2):367–379. 10.1007/s11011-014-9560-1
61. Xue M, Atallah BV, Scanziani M (2014) Equalizing excitation-inhibition ratios across visual cortical neurons. Nature 511(7511):596–600. 10.1038/nature13321
62. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ (2015) Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report 87:1–20
63. Zablotsky B, Bramlett MD, Blumberg SJ (2017) The co-occurrence of autism spectrum disorder in children with ADHD. J Atten Disord 1087054717713638. 10.1177/1087054717713638
64. Zeina RM, Al-Ayadhi L, Bashir S (2014) Autism spectrum disorder: main problem waiting for solution in Kingdom of Saudi Arabia. Int J Med Health Biomed Bioeng Pharm Eng 8:526–529. http://waset.org/publications/9999346. Accessed 2 June 2017